Filing Details

Accession Number:
0001179022-17-000071
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-12-08 16:36:35
Reporting Period:
2017-12-08
Accepted Time:
2017-12-08 16:36:35
Original Submission Date:
2017-12-08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412377 Marc Rubin C/O Galectin Therapeutics, Inc.
4960 Peachtree Industrial Blvd., Ste 240
Norcross GA 30071
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-08 7,000 $1.85 55,581 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The footnote on the original Form 4, filed on December 8, 2017, incorrectly indicated that the shares were sold, instead of purchased, in multiple transactions. The shares were purchased in multiple transactions at prices ranging from $1.819 to $1.92. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.